Estrella Immunopharma, Inc. (ESLAW)
Nasdaq: ESLAW · CIK 0001844417 · United States
Every official Estrella Immunopharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ESLAW filings
Estrella Immunopharma, Inc. documents
- Estrella Immunopharma, Inc. 10-K 2026ESLAW 10-K 2026: annual report for fiscal 2026
- Estrella Immunopharma, Inc. 10-K 2025ESLAW 10-K 2025: annual report for fiscal 2025
- Estrella Immunopharma, Inc. 10-K 2024ESLAW 10-K 2024: annual report for fiscal 2024
- Estrella Immunopharma, Inc. 10-K 2023ESLAW 10-K 2023: annual report for fiscal 2023
- Estrella Immunopharma, Inc. 10-K 2022ESLAW 10-K 2022: annual report for fiscal 2022
- Estrella Immunopharma, Inc. 10-Q 2026ESLAW 10-Q 2026: quarterly report for fiscal 2026
- Estrella Immunopharma, Inc. 10-Q 2025ESLAW 10-Q 2025: quarterly report for fiscal 2025
- Estrella Immunopharma, Inc. 10-Q 2024ESLAW 10-Q 2024: quarterly report for fiscal 2024
- Estrella Immunopharma, Inc. 10-Q 2023ESLAW 10-Q 2023: quarterly report for fiscal 2023
- Estrella Immunopharma, Inc. 10-Q 2022ESLAW 10-Q 2022: quarterly report for fiscal 2022
- Estrella Immunopharma, Inc. 8-K 2026ESLAW 8-K 2026: current report for fiscal 2026
- Estrella Immunopharma, Inc. 8-K 2025ESLAW 8-K 2025: current report for fiscal 2025
- Estrella Immunopharma, Inc. 8-K 2024ESLAW 8-K 2024: current report for fiscal 2024
- Estrella Immunopharma, Inc. 8-K 2023ESLAW 8-K 2023: current report for fiscal 2023
- Estrella Immunopharma, Inc. 8-K 2022ESLAW 8-K 2022: current report for fiscal 2022
- Estrella Immunopharma, Inc. DEF 14A 2026ESLAW DEF 14A 2026: proxy statement for fiscal 2026
- Estrella Immunopharma, Inc. DEF 14A 2025ESLAW DEF 14A 2025: proxy statement for fiscal 2025
- Estrella Immunopharma, Inc. DEF 14A 2024ESLAW DEF 14A 2024: proxy statement for fiscal 2024
- Estrella Immunopharma, Inc. DEF 14A 2023ESLAW DEF 14A 2023: proxy statement for fiscal 2023
- Estrella Immunopharma, Inc. DEF 14A 2022ESLAW DEF 14A 2022: proxy statement for fiscal 2022
- Estrella Immunopharma, Inc. Form 4 2026ESLAW Form 4 2026: insider trading filing for fiscal 2026
- Estrella Immunopharma, Inc. Form 4 2025ESLAW Form 4 2025: insider trading filing for fiscal 2025
- Estrella Immunopharma, Inc. Form 4 2024ESLAW Form 4 2024: insider trading filing for fiscal 2024
- Estrella Immunopharma, Inc. Form 4 2023ESLAW Form 4 2023: insider trading filing for fiscal 2023
- Estrella Immunopharma, Inc. Form 4 2022ESLAW Form 4 2022: insider trading filing for fiscal 2022
- Estrella Immunopharma, Inc. S-1 2026ESLAW S-1 2026: registration statement for fiscal 2026
- Estrella Immunopharma, Inc. S-1 2025ESLAW S-1 2025: registration statement for fiscal 2025
- Estrella Immunopharma, Inc. S-1 2024ESLAW S-1 2024: registration statement for fiscal 2024
- Estrella Immunopharma, Inc. S-1 2023ESLAW S-1 2023: registration statement for fiscal 2023
- Estrella Immunopharma, Inc. S-1 2022ESLAW S-1 2022: registration statement for fiscal 2022
- Estrella Immunopharma, Inc. 13F 2026ESLAW 13F 2026: institutional holdings for fiscal 2026
- Estrella Immunopharma, Inc. 13F 2025ESLAW 13F 2025: institutional holdings for fiscal 2025
- Estrella Immunopharma, Inc. 13F 2024ESLAW 13F 2024: institutional holdings for fiscal 2024
- Estrella Immunopharma, Inc. 13F 2023ESLAW 13F 2023: institutional holdings for fiscal 2023
- Estrella Immunopharma, Inc. 13F 2022ESLAW 13F 2022: institutional holdings for fiscal 2022
More companies